Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate

CONTEXT: Intermittent 3-month cyclic administration might optimize the anabolic potential of teriparatide (TPTD). OBJECTIVE: To determine whether 3-month cyclical TPTD would produce a similar bone mineral density (BMD) response to daily therapy in treatment naive (Rx-naive) women and to confirm the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Endocrinol Metab
Glavni autori: Cosman, Felicia, Nieves, Jeri W., Zion, Marsha, Garrett, Patricia, Neubort, Simon, Dempster, David, Lindsay, Robert
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2015
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5393523/
https://ncbi.nlm.nih.gov/pubmed/25961136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-1715
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items